Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124988142 | 12498814 | 2 | F | 20160722 | 20160627 | 20160801 | EXP | KR-MLMSERVICE-20160609-0315856-1 | KR-ACCORD-041852 | ACCORD | NAM S, KANG J, CHOI S-E, KIM YR, BAIK SH, SOHN S-K. XANTHOGRANULOMATOUS APPENDICITIS MIMICKING RESIDUAL BURKITT^S LYMPHOMA AFTER CHEMOTHERAPY. ANNALS OF COLOPROCTOLOGY. 2016; 32(2): 83-86 | 23.00 | YR | F | Y | 0.00000 | 20160801 | OT | KR | KR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124988142 | 12498814 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | 40716 | ||||||||||||
| 124988142 | 12498814 | 2 | SS | CYCLOPHOSPHAMIDE/CYCLOPHOSPHAMIDE MONOHYDRATE | CYCLOPHOSPHAMIDE | 1 | TOTAL OF 8 CYCLES | 0 | |||||||||||
| 124988142 | 12498814 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | TOTAL OF 8 CYCLES | 0 | |||||||||||
| 124988142 | 12498814 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | TOTAL OF 8 CYCLES | 0 | |||||||||||
| 124988142 | 12498814 | 5 | SS | CYTARABINE/CYTARABINE HYDROCHLORIDE/CYTARABINE OCFOSFATE | CYTARABINE | 1 | TOTAL OF 8 CYCLES | 0 | |||||||||||
| 124988142 | 12498814 | 6 | SS | MESNA. | MESNA | 1 | 0 | ||||||||||||
| 124988142 | 12498814 | 7 | SS | FOLINIC ACID | LEUCOVORIN | 1 | 0 | ||||||||||||
| 124988142 | 12498814 | 8 | SS | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 0 | ||||||||||||
| 124988142 | 12498814 | 9 | SS | DOXORUBICIN | DOXORUBICIN | 1 | TOTAL OF 8 CYCLES | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124988142 | 12498814 | 1 | Burkitt's lymphoma |
| 124988142 | 12498814 | 2 | Burkitt's lymphoma |
| 124988142 | 12498814 | 3 | Burkitt's lymphoma |
| 124988142 | 12498814 | 4 | Burkitt's lymphoma |
| 124988142 | 12498814 | 5 | Burkitt's lymphoma |
| 124988142 | 12498814 | 6 | Burkitt's lymphoma |
| 124988142 | 12498814 | 7 | Burkitt's lymphoma |
| 124988142 | 12498814 | 8 | Burkitt's lymphoma |
| 124988142 | 12498814 | 9 | Burkitt's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124988142 | 12498814 | HO |
| 124988142 | 12498814 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124988142 | 12498814 | Appendicitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124988142 | 12498814 | 1 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 2 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 3 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 4 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 5 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 6 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 7 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 8 | 201304 | 201311 | 0 | |
| 124988142 | 12498814 | 9 | 201304 | 201311 | 0 |